Thomas Gidoin Joins OSE Immunotherapeutics as Chief Financial Officer
August 20, 2025 - 23:13
NANTES, France, August 20, 2025 – OSE Immunotherapeutics SA has officially announced the appointment of Thomas Gidoin as its new Chief Financial Officer. With over 15 years of extensive experience in capital markets and financial strategy, Gidoin brings a wealth of knowledge and expertise to the company’s Executive Committee.
Gidoin's background in biopharma finance is marked by a strong track record in strategic financial leadership, which he has demonstrated in both private and public sectors. His appointment is anticipated to enhance OSE Immunotherapeutics' financial governance and strategic initiatives, positioning the company for future growth and success.
The addition of Gidoin to the leadership team is seen as a pivotal move to strengthen the company's financial operations and align its strategies with the evolving landscape of the biopharmaceutical industry. Stakeholders and investors alike are looking forward to the insights and direction he will bring in his new role.
MORE NEWS
July 10, 2026 - 02:26
Delta Q2 earnings preview: What to watchDelta Air Lines is set to release its second quarter financial results on Friday morning, and Wall Street is watching closely for signs that the airline`s premium cabin strategy can offset mounting...
July 9, 2026 - 12:49
PayPal, Ameriprise Financial, and Ally Financial Shares Are Falling, What You Need To KnowShares of PayPal, Ameriprise Financial, and Ally Financial dropped sharply in afternoon trading on Monday as a wave of risk aversion swept through the markets. The sell-off followed President Trump...
July 8, 2026 - 18:21
Aussie cafe owner reveals grim cost-of-living reality facing millions: 'Race to the bottom'A small business owner in Australia has opened up about the brutal financial pressures facing millions of people as the cost of living continues to climb. Bec Bremner, who runs a bakery and cafe,...
July 8, 2026 - 04:48
Bloom Energy (BE) Could Be 20% Undervalued As Brookfield Expands Its Financing FrameworkBloom Energy (BE) is drawing fresh attention from investors after Brookfield expanded its financing framework for Bloom-powered AI infrastructure projects. The commitment was raised from $5 billion...